Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Antineoplastics/elasomeran

Multiple toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Watts C, et al. Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib. Journal of Oncology Pharmacy Practice 29: 962-966, No. 4, 24 Aug 2022. Available from: URL: http://doi.org/10.1177/10781552221122057 Watts C, et al. Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib. Journal of Oncology Pharmacy Practice 29: 962-966, No. 4, 24 Aug 2022. Available from: URL: http://​doi.​org/​10.​1177/​1078155222112205​7
Metadaten
Titel
Antineoplastics/elasomeran
Multiple toxicities: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-43044-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Dasatinib

Case report

Ruxolitinib

Case report

Insulin detemir